2.50
Hdl Handle:
http://hdl.handle.net/10541/85565
Title:
Vaccines in oncology: background and clinical potential.
Authors:
Armstrong, Anne C; Hawkins, Robert E
Abstract:
Cancer is one of the leading causes of death in Western society. Despite improvements in screening, diagnosis and treatment of cancer, many patients ultimately succumb to their disease. Advances in molecular biology and our increased understanding of how the immune system functions have led to an intense interest in the development of cancer vaccines.
Affiliation:
CRC Department of Medical Oncology, University of Manchester & Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester M20 4BX, UK.
Citation:
Vaccines in oncology: background and clinical potential. 2001, 74 (887):991-1002 Br J Radiol
Journal:
The British Journal of Radiology
Issue Date:
Nov-2001
URI:
http://hdl.handle.net/10541/85565
PubMed ID:
11709463
Type:
Article
Language:
en
ISSN:
0007-1285
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorArmstrong, Anne Cen
dc.contributor.authorHawkins, Robert Een
dc.date.accessioned2009-11-06T14:58:36Z-
dc.date.available2009-11-06T14:58:36Z-
dc.date.issued2001-11-
dc.identifier.citationVaccines in oncology: background and clinical potential. 2001, 74 (887):991-1002 Br J Radiolen
dc.identifier.issn0007-1285-
dc.identifier.pmid11709463-
dc.identifier.urihttp://hdl.handle.net/10541/85565-
dc.description.abstractCancer is one of the leading causes of death in Western society. Despite improvements in screening, diagnosis and treatment of cancer, many patients ultimately succumb to their disease. Advances in molecular biology and our increased understanding of how the immune system functions have led to an intense interest in the development of cancer vaccines.en
dc.language.isoenen
dc.subjectCancer Antigensen
dc.subjectTumour Suppressor Genesen
dc.subjectCanceren
dc.subject.meshAntigens, Neoplasm-
dc.subject.meshAntigens, Viral-
dc.subject.meshAutoimmune Diseases-
dc.subject.meshCancer Vaccines-
dc.subject.meshCarcinoembryonic Antigen-
dc.subject.meshDendritic Cells-
dc.subject.meshEpitopes-
dc.subject.meshGenes, Tumor Suppressor-
dc.subject.meshHistocompatibility Antigens Class I-
dc.subject.meshHumans-
dc.subject.meshImmune Tolerance-
dc.subject.meshImmunoglobulin Idiotypes-
dc.subject.meshMutation-
dc.subject.meshNeoplasms-
dc.subject.meshT-Lymphocytes-
dc.subject.meshT-Lymphocytes, Cytotoxic-
dc.titleVaccines in oncology: background and clinical potential.en
dc.typeArticleen
dc.contributor.departmentCRC Department of Medical Oncology, University of Manchester & Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester M20 4BX, UK.en
dc.identifier.journalThe British Journal of Radiologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.